December 2021

DECEMBER 2021 MEETINGS

You can now access this webinar directly by clicking on the link below.

MEETING SUMMARY
Title: YO GERSO Glaucoma: Ocular Hypertension Date: Saturday, 18th December, 2021 Time: 13.15-15.30 GMT, 08.15-10.30 EST, 21.15-23.30 SGT, 05.15-07.30 PST, 18.45-21.00 IST
Moderator: Dr. Jonathan Yu 1) Ocular hypertension vs POAG – what is the difference? – Dr. Frances Meier-Gibbons, Switzerland 2) Summary of OHTS/EMGT/UKGTS studies – Dr. Jonathan Kirk, UK 3) Should we be using SLT or eye drops for OHT/early glaucoma? – Dr. Joanna Przeździecka-Dołyk, Poland

MEETING SUMMARY

Date: Saturday, 18th December, 2021

Time: 13.15-15.30 GMT, 08.15-10.30 EST, 21.15-23.30 SGT, 05.15-07.30 PST, 18.45-21.00 IST

Moderator: Dr. Jonathan Yu

1) Ocular hypertension vs POAG – what is the difference? – Dr. Frances Meier-Gibbons, Switzerland

2) Summary of OHTS/EMGT/UKGTS studies – Dr. Jonathan Kirk, UK

3) Should we be using SLT or eye drops for OHT/early glaucoma? – Dr. Joanna Przeździecka-Dołyk, Poland

You can now access this webinar directly by clicking on the link below.

MEETING SUMMARY
Title: Advanced and Intermediate: Do We Still Need the Subconjunctival Space? Date: Sunday, 19th December, 2021 Time: 13.15-15.30 GMT, 08.15-10.30 EST, 21.15-23.30 SGT, 05.15-07.30 PST, 18.45-21.00 IST
Moderators: Dr. Paul Harasymowycz, Canada and Dr. Paul Singh, USA 1) Tubes or Trabs – Which One Should We Do First? – Dr. Tarek Shaarawy, Switzerland 2) Evolution of Subconjunctival MIGS – From Xen to Preserflo – Dr. Paul Harasymowycz, Canada 3) Revisiting the Conventional Pathway After a Subconjunctival Surgery – is it worthwhile? – Dr. Paul Singh, USA 4) Putting It All Together – When, How, and Why Do We Choose the Subconjunctival Space in the Era of MIGS – Dr. Ike Ahmed, Canada

MEETING SUMMARY

Date: Sunday, 19th December, 2021

Time: 13.15-15.30 GMT, 08.15-10.30 EST, 21.15-23.30 SGT, 05.15-07.30 PST, 18.45-21.00 IST

Moderators: Dr. Paul Harasymowycz, Canada and Dr. Paul Singh, USA

1) Tubes or Trabs – Which One Should We Do First? – Dr. Tarek Shaarawy, Switzerland

2) Evolution of Subconjunctival MIGS – From Xen to Preserflo – Dr. Paul Harasymowycz, Canada

3) Revisiting the Conventional Pathway After a Subconjunctival Surgery – is it worthwhile? – Dr. Paul Singh, USA

4) Putting It All Together – When, How, and Why Do We Choose the Subconjunctival Space in the Era of MIGS – Dr. Ike Ahmed, Canada